Search

Search Results

• 

  Appropriateness and cost-effectiveness in the treatment of invasive candidiasis in Internal Medicine Wards

  Enrico Tagliaferri, Francesco Menichetti

  221-224

  04-12-2014

  https://doi.org/10.4081/itjm.2014.536

  1535

  PDF: 1066

  HTML: 374
• 

  Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 3. Clinical issues

  Roberto Nardi, Marco Masina, Giorgio Cioni, Paolo Leandri, Paola Zuccheri

  99-109

  08-05-2014

  https://doi.org/10.4081/itjm.2014.400

  2509

  PDF: 1523

  HTML: 780
• 

  Candidemia in Internal Medicine Wards: a real problem or just an epiphenomenon?

  Matteo Bassetti, Alessia Cargnelutti, Federico Silvestri

  205-207

  02-09-2014

  https://doi.org/10.4081/itjm.2014.510

  1388

  PDF: 995

  HTML: 339

• CO13 | Macrophage activation syndrome successfully treated with eculizumab and emapalumab: a case report C. Ferrari, L. Castelnovo, L. Marchionni, P. Faggioli, A. Mazzone | ASST Ovest Milanese, Ospedale di Legnano (MI), Italy

  25-08-2025

  https://doi.org/10.4081/itjm.2025.2165

  254
• 

  Sex differences in adverse drug reaction and liver disease

  Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

  15-22

  20-03-2018

  https://doi.org/10.4081/itjm.2018.893

  2425

  PDF: 1089

  HTML: 500
• 

  Management of stable coronary artery disease: from evidence to clinical practice

  Riccardo Gerloni, Luciano Mucci, Tiziana Ciarambino, Manuel Ventura, Valeria Baglio, Massimiliano Chiuch, Francesca Saladini, Stefania Dorigoni, Davide Tizzani, Paola Gnerre

  114-133

  14-06-2017

  https://doi.org/10.4081/itjm.2017.755

  2950

  PDF: 1344

  HTML: 1808